BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 11042273)

  • 1. A potential role for p15(Ink4b) and p57(Kip2) in liver development.
    Awad MM; Sanders JA; Gruppuso PA
    FEBS Lett; 2000 Oct; 483(2-3):160-4. PubMed ID: 11042273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent and heterogenous expression of the cyclin-dependent kinase inhibitor, p27KIP1, in rat hearts during development.
    Koh KN; Kang MJ; Frith-Terhune A; Park SK; Kim I; Lee CO; Koh GY
    J Mol Cell Cardiol; 1998 Mar; 30(3):463-74. PubMed ID: 9515024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development.
    Chellappan SP; Giordano A; Fisher PB
    Curr Top Microbiol Immunol; 1998; 227():57-103. PubMed ID: 9479826
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of cyclin dependent kinase inhibitor proteins during neonatal cerebella development.
    Watanabe G; Pena P; Shambaugh GE; Haines GK; Pestell RG
    Brain Res Dev Brain Res; 1998 Jun; 108(1-2):77-87. PubMed ID: 9693786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased proliferation and cell cycle arrest in neoplastic rat pituitary cells is associated with transforming growth factor-beta1-induced expression of p15/INK4B.
    Frost SJ; Simpson DJ; Farrell WE
    Mol Cell Endocrinol; 2001 May; 176(1-2):29-37. PubMed ID: 11369440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
    Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells.
    Schwarze SR; Shi Y; Fu VX; Watson PA; Jarrard DF
    Oncogene; 2001 Dec; 20(57):8184-92. PubMed ID: 11781834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel expression of cyclin-dependent kinase inhibitors in human B-cell precursors.
    Fink JR; LeBien TW
    Exp Hematol; 2001 Apr; 29(4):490-8. PubMed ID: 11301189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
    Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
    Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines.
    Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Akagi M; Tahara H; Ishikawa T; Tahara E
    Jpn J Cancer Res; 1996 Aug; 87(8):824-30. PubMed ID: 8797888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
    Schreiber M; Muller WJ; Singh G; Graham FL
    Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p15INK⁴b and p57KIP² and relationship with clinicopathological features and prognosis in patients with vulvar squamous cell carcinoma.
    Holm R; Førsund M; Nguyen MT; Nesland JM; Trope CG
    PLoS One; 2013; 8(4):e61273. PubMed ID: 23580324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain.
    Joaquin M; Watson RJ
    J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulators of cyclin-dependent kinases and their roles in cancers.
    Lee MH; Yang HY
    Cell Mol Life Sci; 2001 Nov; 58(12-13):1907-22. PubMed ID: 11766887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells.
    Komata T; Kanzawa T; Takeuchi H; Germano IM; Schreiber M; Kondo Y; Kondo S
    Br J Cancer; 2003 Apr; 88(8):1277-80. PubMed ID: 12698196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood.
    Takeuchi S; Bartram CR; Seriu T; Miller CW; Tobler A; Janssen JW; Reiter A; Ludwig WD; Zimmermann M; Schwaller J
    Blood; 1995 Jul; 86(2):755-60. PubMed ID: 7606004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis.
    Latres E; Malumbres M; Sotillo R; Martín J; Ortega S; Martín-Caballero J; Flores JM; Cordón-Cardo C; Barbacid M
    EMBO J; 2000 Jul; 19(13):3496-506. PubMed ID: 10880462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d).
    Zindy F; den Besten W; Chen B; Rehg JE; Latres E; Barbacid M; Pollard JW; Sherr CJ; Cohen PE; Roussel MF
    Mol Cell Biol; 2001 May; 21(9):3244-55. PubMed ID: 11287627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
    Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.